The Daily Wrap – May 18, 2026

We saw major corporate activity, led by NextEra's massive acquisition of Dominion to power the AI boom and SpaceX's accelerated plans for a historic IPO. This corporate dynamism contrasted with significant market headwinds, including stock-specific setbacks for UnitedHealth and Regeneron, and the broader economic threat of war-driven inflation. This inflation is causing oil price volatility and a spike in bond yields, creating significant risks for the housing market and the stock market's recent rally.

A news podcast encapsulating the most salient market news, brought to you by Finextra Pro and powered by Communify.

Open Finextra Pro now!

Transcript

SPEAKER_00 0:00

From Phoenixtra Pro in Tampa, it's Monday, May 18th. And I'm Rachel Anderson with the Daily Rap. NextEra Energy has announced it will acquire Dominion Energy in an all-stock deal valued at nearly $67 billion. The move creates the world's largest regulated electric utility by market value and highlights a wave of consolidation as companies race to power the data centers fueling the AI revolution. Ford's Energy Unit announced a five-year deal to supply up to 20 gigawatt hours of battery storage capacity to renewable power developer EDF. Ford is repurposing infrastructure originally built for its electric vehicle programs to cash in on the soaring demand for backup power systems needed to support the nation's strained energy grid. Elon Musk SpaceX has informed investors it will implement a 5 for 1 stock split, a move designed to make its shares more attractive ahead of its IPO. According to reports, the company is now aiming to price its initial public offering as early as June 11, with shares potentially trading on the NASDAQ the very next day. SpaceX is said to be targeting a valuation nearing an astronomical $1.8 trillion, which would easily top its sister company Tesla. Shares of United Health Group are sliding, after a new filing revealed that Warren Buffett's Berkshire Hathaway has completely exited its position, selling its entire stake of more than 5 million shares in the last quarter. The move comes from the first 13F filing under new Berkshire CEO Greg Abel and is putting pressure on the health insurer, which has been executing a turnaround plan to combat high medical costs and regulatory headwinds. And Regeneron Pharmaceuticals saw its stock drop by more than 10% today after the biotech firm announced a major setback. A late-stage trial for its experimental melanoma drug, Fion Limob, failed to meet its main goal of showing a statistically significant improvement over Merck's blockbuster treatment, Kitruda. The news prompted a flurry of downgrades on Wall Street, and adds to concerns over Regeneron's ILA franchise, which is facing increased competition and regulatory delays, oil prices are continuing to stay high, even after unconfirmed reports from Iranian media that the U.S. has offered a temporary waiver on oil sanctions. However, the underlying supply situation remains critical. The International Energy Agency is warning that global oil inventories are depleting at a record pace as the Strait of Hormuz remains mostly closed. Experts caution that while there is no physical shortage yet, Europe could begin to feel the pinch by the end of the month, just as the summer driving season kicks off in the US. That risk of sustained high energy prices is fueling warnings on Wall Street, that the stock market is unprepared for a new inflation regime. And a recent spike in bond yields, with the 30-year Treasury topping 5%, signals that the fixed income market is taking the inflation threat seriously. Investors warn that equities, which have largely shrugged off the risks, are vulnerable to a sharp correction if high inflation becomes embedded in the economy. Home builder sentiment ticked up slightly in May, but it remains deeply pessimistic, marking the 25th straight month below the break-even point. Builders cite war-stoked inflation, which is elevating material costs and pushing mortgage rates higher as a primary reason for the soft demand and significant affordability challenges facing potential buyers. U.S. Treasury yields are still on the rise but have stabilized somewhat after the spike at the end of last week. The 10-year is at 4.60%, the two-year yield is at 4.07%, and the 30-year bond yield is at 5.13%. And now, let's check the scoreboard. Wall Street is seeing a dip today as it digests news out of the Middle East and inflation concerns. Midday the SP was down around two tenths of a percent, the Dow was down just over a tenth of a percent, and the MASDAC was down roughly 1%. That's all for your daily rap today. I'm Rachel Anderson from Phoenixstra Pro, turning data into stories.